TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Hishiki, T. [1 ]
Horie, H. [2 ]
Higashimoto, Y. [1 ]
Yotsumoto, K. [1 ]
Komatsu, S. [1 ]
Okimoto, Y. [3 ]
Kakuda, H. [3 ]
Taneyamai, Y. [3 ]
Yoshida, H. [4 ]
Iwai, J. [1 ]
机构：
[1] Chiba Childrens Hosp, Dept Pediat Surg, Chiba, Japan
[2] Chiba Childrens Hosp, Dept Pathol, Chiba, Japan
[3] Chiba Childrens Hosp, Dept Hematol & Oncol, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-348
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [1] Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma
    Tomoro Hishiki
    Hiroshi Horie
    Yasuyuki Higashimoto
    Katsumi Yotsumoto
    Shugo Komatsu
    Yuri Okimoto
    Harumi Kakuda
    Yuichi Taneyama
    Takeshi Saito
    Keita Terui
    Tetsuya Mitsunaga
    Mitsuyuki Nakata
    Hidemasa Ochiai
    Moeko Hino
    Kumiko Ando
    Hideo Yoshida
    Jun Iwai
    Pediatric Surgery International, 2014, 30 : 919 - 926
  • [2] INDUCTION CHEMOTHERAPY BASED ON HIGH-DOSE TOPOTECAN IN HIGH-RISK NEUROBLASTOMA: RESPONSE RATE AND SURVIVAL
    De Loris, Maria Antonietta
    Ilari, Ilaria
    Jenkner, Alessandro
    Castellano, Aurora
    De Sio, Luigi
    Rava, Lucilla
    De Pasquale, Maria Debora
    De laurentis, Clementina
    Donfrancesco, Alberto
    Locatelli, Franco
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 891 - 891
  • [3] Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma
    Hishiki, Tomoro
    Horie, Hiroshi
    Higashimoto, Yasuyuki
    Yotsumoto, Katsumi
    Komatsu, Shugo
    Okimoto, Yuri
    Kakuda, Harumi
    Taneyama, Yuichi
    Saito, Takeshi
    Terui, Keita
    Mitsunaga, Tetsuya
    Nakata, Mitsuyuki
    Ochiai, Hidemasa
    Hino, Moeko
    Ando, Kumiko
    Yoshida, Hideo
    Iwai, Jun
    PEDIATRIC SURGERY INTERNATIONAL, 2014, 30 (09) : 919 - 926
  • [4] TREATMENT OUTCOME OF HIGH-DOSE CHEMOTHERAPY PLUS STEM CELL RESCUE IN HIGH-RISK NEUROBLASTOMA IN THAILAND
    Suwannaying, Kunanya
    Techavichit, Piti
    Patcharee, Patcharee
    Laoaroon, Napat
    Narkbunnam, Nattee
    Sanpakit, Kleebsabai
    Chiengthong, Kanhatai
    Chotsampancharoen, Thirachit
    Sathitsamitphong, Lalita
    Santong, Chalongpon
    Seksarn, Panya
    Hongeng, Suradej
    Wiangnon, Surapon
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S599 - S599
  • [5] Tumor histology during induction therapy in patients with high-risk neuroblastoma
    George, Rani E.
    Perez-Atayde, Antonio R.
    Yao, Xiaopan
    London, Wendy B.
    Shamberger, Robert C.
    Neuberg, Donna
    Diller, Lisa
    PEDIATRIC BLOOD & CANCER, 2012, 59 (03) : 506 - 510
  • [6] End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma, Rabiya S.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) : 618 - U3
  • [7] High-dose sequential chemotherapy in patients with high-risk breast cancer
    Sabbatini, R
    Frassineti, L
    Depenni, R
    BONE MARROW TRANSPLANTATION, 2001, 27 : S119 - S119
  • [8] High-dose chemotherapy in high-risk breast cancer
    Price, LA
    LANCET, 1998, 352 (9139): : 1551 - 1552
  • [9] High-dose chemotherapy in high-risk breast cancer
    de Boer R.
    Breast Cancer Research, 2 (1)
  • [10] Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
    Suwannaying, Kunanya
    Techavichit, Piti
    Komvilaisak, Patcharee
    Laoaroon, Napat
    Narkbunnam, Nattee
    Sanpakit, Kleebsabai
    Chiengthong, Kanhatai
    Chotsampancharoen, Thirachit
    Sathitsamitphong, Lalita
    Santong, Chalongpon
    Seksarn, Panya
    Hongeng, Suradej
    Wiangnon, Surapon
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2022, 65 (09) : 453 - 458
12345